Abbott Laboratories - CEDEAR

Abbott Laboratories - CEDEAR is a Certificado de Depósito Argentino (CEDEAR) representing shares of Abbott Laboratories, a global healthcare company specializing in medical devices, diagnostics, nutritional products, and branded generic medicines. This financial instrument enables Argentine investors to gain exposure to Abbott Laboratories' performance without direct access to U.S. markets, facilitating diversified investment in the healthcare sector. Abbott Laboratories discovers, develops, and sells a broad portfolio of products worldwide, including the FreeStyle Libre continuous glucose monitoring system, cardiovascular and neuromodulation devices, and pediatric and adult nutritionals like Ensure and Pedialyte. The company impacts key industries such as diagnostics, where it holds leadership in rapid testing, and pharmaceuticals through established brands. With a fiscal year ending December 31, strong profitability metrics like a 31.89% profit margin and 30.65% return on equity, and a forward annual dividend reflecting shareholder returns, Abbott Laboratories - CEDEAR plays a significant role in providing local market participants with access to a stable, innovation-driven multinational leader in health solutions.